A detailed history of Moody Aldrich Partners LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Moody Aldrich Partners LLC holds 100,340 shares of AMPH stock, worth $3.95 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares
100,340
Previous 55,734 80.03%
Holding current value
$3.95 Million
Previous $2.23 Million 118.44%
% of portfolio
0.97%
Previous 0.47%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$36.99 - $50.09 $1.65 Million - $2.23 Million
44,606 Added 80.03%
100,340 $4.87 Million
Q2 2024

Jul 23, 2024

SELL
$38.65 - $43.48 $763,105 - $858,469
-19,744 Reduced 26.16%
55,734 $2.23 Million
Q1 2024

Apr 29, 2024

BUY
$42.85 - $63.45 $529,797 - $784,495
12,364 Added 19.59%
75,478 $3.31 Million
Q4 2023

Jan 25, 2024

BUY
$44.49 - $62.93 $2.81 Million - $3.97 Million
63,114 New
63,114 $3.9 Million

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.93B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Moody Aldrich Partners LLC Portfolio

Follow Moody Aldrich Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Aldrich Partners LLC with notifications on news.